The Gut-Brain Axis: The Missing Link in Depression (original) (raw)

1. Khanna, S, and Tosh, PK (2014). A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 89, 107-114.
   
2. Borre, YE, O’Keeffe, GW, Clarke, G, Stanton, C, Dinan, TG, and Cryan, JF (2014). Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 20, 509-518.
   
3. de Vos, WM, and de Vos, EA (2012). Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 70, S45-S56.
   
4. Lozupone, CA, Stombaugh, JI, Gordon, JI, Jansson, JK, and Knight, R (2012). Diversity, stability and resilience of the human gut microbiota. Nature. 489, 220-230.
   
5. , (2012). Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One. 7, e39315.
   
6. Reardon, S (2014). Gut-brain link grabs neuroscientists. Nature. 515, 175-177.
   
7. Flint, HJ (2012). The impact of nutrition on the human microbiome. Nutr Rev. 70, S10-S13.
   
8. Brandt, LJ (2013). American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 108, 177-185.
   
9. O’Mahony, L, McCarthy, J, Kelly, P, Hurley, G, Luo, F, and Chen, K (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 128, 541-551.
   
10. Tosh, PK, and McDonald, LC (2012). Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis. 54, 707-713.
    
11. Martínez, I, Lattimer, JM, Hubach, KL, Case, JA, Yang, J, and Weber, CG (2013). Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 7, 269-280.
    
12. Bäckhed, F, Manchester, JK, Semenkovich, CF, and Gordon, JI (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 104, 979-984.
    
13. Hornig, M (2013). The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol. 25, 488-795.
    
14. Strachan, DP (1989). Hay fever, hygiene, and household size. BMJ. 299, 1259-1260.
    
15. Rook, GA, Martinelli, R, and Brunet, LR (2003). Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr Opin Allergy Clin Immunol. 3, 337-342.
    
16. Rook, GA (2010). 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the ‘hygiene’ or ‘old friends’ hypothesis. Clin Exp Immunol. 160, 70-79.
    
17. Rook, GA, Lowry, CA, and Raison, CL (2015). Hygiene and other early childhood influences on the subsequent function of the immune system. Brain Res. 1617, 47-62.
    
18. Barrett, E, Ross, RP, O’Toole, PW, Fitzgerald, GF, and Stanton, C (2012). γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 113, 411-417.
    
19. Lyte, M (2011). Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. Bioessays. 33, 574-581.
    
20. Desbonnet, L, Garrett, L, Clarke, G, Bienenstock, J, and Dinan, TG (2008). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 43, 164-174.
    
21. Muccioli, GG, Naslain, D, Bäckhed, F, Reigstad, CS, Lambert, DM, and Delzenne, NM (2010). The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 6, 392.
    
22. Collins, SM, and Bercik, P (2009). The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 136, 2003-2014.
    
23. Davey, KJ, O’Mahony, SM, Schellekens, H, O’Sullivan, O, Bienenstock, J, and Cotter, PD (2012). Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl). 221, 155-169.
    
24. Bailey, MT, and Coe, CL (1999). Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol. 35, 146-155.
    
25. O’Mahony, SM, Marchesi, JR, Scully, P, Codling, C, Ceolho, AM, and Quigley, EM (2009). Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry. 65, 263-267.
    
26. Round, JL, O’Connell, RM, and Mazmanian, SK (2010). Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun. 34, J220-J225.
    
27. Olszak, T, An, D, Zeissig, S, Vera, MP, Richter, J, and Franke, A (2012). Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 336, 489-493.
    
28. Neish, AS (2009). Microbes in gastrointestinal health and disease. Gastroenterology. 136, 65-80.
    
29. Dinan, TG, and Quigley, EM (2011). Probiotics in the treatment of depression: science or science fiction?. Aust N Z J Psychiatry. 45, 1023-1025.
    
30. Carvalho, FA, Aitken, JD, Vijay-Kumar, M, and Gewirtz, AT (2012). Toll-like receptor-gut microbiota interactions: perturb at your own risk!. Annu Rev Physiol. 74, 177-198.
    
31. Lucas, K, and Maes, M (2013). Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 48, 190-204.
    
32. Takeuchi, O, and Akira, S (2010). Pattern recognition receptors and inflammation. Cell. 140, 805-820.
    
33. McKernan, DP, Dennison, U, Gaszner, G, Cryan, JF, and Dinan, TG (2011). Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry. 1, e36.
    
34. McCusker, RH, and Kelley, KW (2013). Immune-neural connections: how the immune system’s response to infectious agents influences behavior. J Exp Biol. 216, 84-98.
    
35. Udina, M, Castellví, P, Moreno-España, J, Navinés, R, Valdés, M, and Forns, X (2012). Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 73, 1128-1138.
    
36. McNutt, MD, Liu, S, Manatunga, A, Royster, EB, Raison, CL, and Woolwine, BJ (2012). Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology. 37, 1444-1454.
    
37. Ma, M, Ren, Q, Zhang, JC, and Hashimoto, K (2014). Effects of Brilliant Blue G on serum tumor necrosis factor-α levels and depression-like behavior in mice after lipopolysaccharide administration. Clin Psychopharmacol Neurosci. 12, 31-36.
    
38. Maes, M, Kenis, G, Kubera, M, De Baets, M, Steinbusch, H, and Bosmans, E (2005). The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. Int Immunopharmacol. 5, 609-618.
    
39. Levkovich, T, Poutahidis, T, Smillie, C, Varian, BJ, Ibrahim, YM, and Lakritz, JR (2013). Probiotic bacteria induce a ‘glow of health’. PLoS One. 8, e53867.
    
40. Macpherson, AJ, and Uhr, T (2002). Gut flora--mechanisms of regulation. Eur J Surg Suppl. , 53-57.
41. Kopp, MV, Goldstein, M, Dietschek, A, Sofke, J, Heinzmann, A, and Urbanek, R (2008). Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates. Clin Exp Allergy. 38, 602-610.
    
42. Costello, EK, Stagaman, K, Dethlefsen, L, Bohannan, BJ, and Relman, DA (2012). The application of ecological theory toward an understanding of the human microbiome. Science. 336, 1255-1262.
    
43. Fetissov, SO, and Déchelotte, P (2011). The new link between gut-brain axis and neuropsychiatric disorders. Curr Opin Clin Nutr Metab Care. 14, 477-482.
    
44. Ait-Belgnaoui, A, Durand, H, Cartier, C, Chaumaz, G, Eutamene, H, and Ferrier, L (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 37, 1885-1895.
    
45. Smythies, LE, and Smythies, JR (2014). Microbiota, the immune system, black moods and the brain-melancholia updated. Front Hum Neurosci. 8, 720.
    
46. Severance, EG, Gressitt, KL, Stallings, CR, Origoni, AE, Khushalani, S, and Leweke, FM (2013). Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res. 148, 130-137.
    
47. O’Mahony, SM, Clarke, G, Borre, YE, Dinan, TG, and Cryan, JF (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 277, 32-48.
    
48. Wren, AM, and Bloom, SR (2007). Gut hormones and appetite control. Gastroenterology. 132, 2116-2130.
    
49. Macfarlane, S, and Macfarlane, GT (2003). Regulation of short-chain fatty acid production. Proc Nutr Soc. 62, 67-72.
    
50. Macfabe, DF (2012). Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 23, .
    
51. Kimura, I, Ozawa, K, Inoue, D, Imamura, T, Kimura, K, and Maeda, T (2013). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 4, 1829.
    
52. Wang, X, Wang, BR, Zhang, XJ, Xu, Z, Ding, YQ, and Ju, G (2002). Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats. World J Gastroenterol. 8, 540-545.
    
53. Borovikova, LV, Ivanova, S, Zhang, M, Yang, H, Botchkina, GI, and Watkins, LR (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405, 458-462.
    
54. Perez-Burgos, A, Wang, B, Mao, YK, Mistry, B, McVey Neufeld, KA, and Bienenstock, J (2013). Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am J Physiol Gastrointest Liver Physiol. 304, G211-G220.
    
55. Diaz Heijtz, R, Wang, S, Anuar, F, Qian, Y, Björkholm, B, and Samuelsson, A (2011). Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 108, 3047-3052.
    
56. Douglas-Escobar, M, Elliott, E, and Neu, J (2013). Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr. 167, 374-379.
    
57. Lyte, M, Varcoe, JJ, and Bailey, MT (1998). Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav. 65, 63-68.
    
58. Desbonnet, L, Garrett, L, Clarke, G, Kiely, B, Cryan, JF, and Dinan, TG (2010). Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 170, 1179-1188.
    
59. Dinan, TG, Stanton, C, and Cryan, JF (2013). Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 74, 720-726.
    
60. Neufeld, KA, Kang, N, Bienenstock, J, and Foster, JA (2011). Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol. 4, 492-494.
    
61. Clarke, G, Grenham, S, Scully, P, Fitzgerald, P, Moloney, RD, and Shanahan, F (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 18, 666-673.
    
62. Messaoudi, M, Lalonde, R, Violle, N, Javelot, H, Desor, D, and Nejdi, A (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 105, 755-764.
    
63. Messaoudi, M, Violle, N, Bisson, JF, Desor, D, Javelot, H, and Rougeot, C (2011). Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2, 256-261.
    
64. Bravo, JA, Forsythe, P, Chew, MV, Escaravage, E, Savignac, HM, and Dinan, TG (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 108, 16050-16055.
    
65. Ohland, CL, Kish, L, Bell, H, Thiesen, A, Hotte, N, and Pankiv, E (2013). Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 38, 1738-1747.
    
66. Naseribafrouei, A, Hestad, K, Avershina, E, Sekelja, M, Linløkken, A, and Wilson, R (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 26, 1155-1162.
    
67. Tillisch, K, Labus, J, Kilpatrick, L, Jiang, Z, Stains, J, and Ebrat, B (2013). Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 144, 1394-1401.
    
68. Berk, M, Williams, LJ, Jacka, FN, O’Neil, A, Pasco, JA, and Moylan, S (2013). So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 11, 200.
    
69. Dash, S, Clarke, G, Berk, M, and Jacka, FN (2015). The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 28, 1-6.
    
70. Phillips, JGP (1910). The treatment of melancholia by the lactic acid bacillus. Br J Psychiatry. 56, 422-431.
    
71. Vanderhoof, JA, and Young, R (2008). Probiotics in the United States. Clin Infect Dis. 46, S67-S72.
    
72. Fond, G, Boukouaci, W, Chevalier, G, Regnault, A, Eberl, G, and Hamdani, N (2015). The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: a systematic review. Pathol Biol (Paris). 63, 35-42.
    
73. Smits, LP, Bouter, KE, de Vos, WM, Borody, TJ, and Nieuwdorp, M (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 145, 946-953.
    
74. Evrensel, A, and Ceylan, ME (2015). Gut-brain axis: the role of gut microbiota in the psychiatric disorders. Curr Approach Psychiatry. 7, 461-472.